Cited by 601Gastrointestinal motility and disordersBarrier Structure and Function StudiesInflammatory Bowel Disease

IL-1β Causes an Increase in Intestinal Epithelial Tight Junction Permeability

Open access
Al-Sadi, Rana M, Ma, Thomas Y·2007·The Journal of Immunology

Abstract

IL-1β is a prototypical proinflammatory cytokine that plays a central role in the intestinal inflammation amplification cascade. Recent studies have indicated that a TNF-α- and IFN-γ-induced increase in intestinal epithelial paracellular permeability may be an important mechanism contributing to intestinal inflammation. Despite its central role in promoting intestinal inflammation, the role of IL-1β on intestinal epithelial tight junction (TJ) barrier function remains unclear. The major aims of this study were to determine the effect of IL-1β on intestinal epithelial TJ permeability and to elucidate the mechanisms involved in this process, using a well-established in vitro intestinal epithelial model system consisting of filter-grown Caco-2 intestinal epithelial monolayers. IL-1β (0–100 ng/ml) produced a concentration- and time-dependent decrease in Caco-2 transepithelial resistance. Conversely, IL-1β caused a progressive time-dependent increase in transepithelial permeability to paracellular marker inulin. IL-1β-induced increase in Caco-2 TJ permeability was accompanied by a rapid activation of NF-κB. NF-κB inhibitors, pyrrolidine dithiocarbamate and curcumin, prevented the IL-1β-induced increase in Caco-2 TJ permeability. To further confirm the role of NF-κB in the IL-1β-induced increase in Caco-2 TJ permeability, NF-κB p65 expression was silenced by small interfering RNA transfection. NF-κB p65 depletion completely inhibited the IL-1β-induced increase in Caco-2 TJ permeability. IL-1β did not induce apoptosis in the Caco-2 cell. In conclusion, our findings show for the first time that IL-1β at physiologically relevant concentrations causes an increase in intestinal epithelial TJ permeability. The IL-1β-induced increase in Caco-2 TJ permeability was mediated in part by the activation of NF-κB pathways but not apoptosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.178.7.4641

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased serum concentrations of TNF, IL-1β, and IL-6 are potent inducers of intestinal permeability.

    “Increased serum concentrations of TNF, IL-1β, and IL-6 have also been shown to be potent inducers of intestinal permeability50–53.”

    From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [51]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Al-Sadi, R. M., & Ma, T. Y.
Affiliations
  • Department of Internal Medicine, University of New Mexico School of Medicine , Albuquerque, NM 87131
  • University of New Mexico (US)
Venue
The Journal of Immunology
Published
2007-04-01
Volume
178
Issue
7
Pages
4641-4649
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1618627661
Cited by
601
References
53
Citations by year
2026: 33 · 2025: 32 · 2024: 39 · 2023: 32 · 2022: 47 · 2021: 42 · 2020: 38 · 2019: 38 · 2018: 34 · 2017: 32 · 2016: 28 · 2015: 29 · 2014: 34 · 2013: 31 · 2012: 30
FWCI
18.67
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK064165, R0-1-DK-64165–01)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
Keywords
IL-1β, tight junction permeability, intestinal epithelial barrier, NF-κB activation, Caco-2 cells, intestinal inflammation, paracellular permeability, inulin permeability, pyrrolidine dithiocarbamate, curcumin, NF-κB p65, transepithelial electrical resistance
MeSH terms
Curcumin, Humans, Intestinal Mucosa, Membrane Proteins, Permeability, Pyrrolidines, RNA, Messenger, Thiocarbamates, NF-kappa B, Apoptosis, Caco-2 Cells, Tight Junctions, Interleukin-1beta, Occludin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review